Skip to main content
. 2004 Aug 10;91(6):1038–1044. doi: 10.1038/sj.bjc.6602105

Table 3. Adverse events reported in patients (n=30) during CE (115 cycles).

  NCI-CTC grade 3 or 4
Adverse event No. of patients %
Thrombocytopenia 0 0
Neutropenia 6 20
Nausea 0 0
Vomiting 0 0
Constipation 0 0
Ototoxicity 1 3.3